Response to the Letter to the Editor Regarding Zeukeng et al.'s article A Comparison of New Drugs Approved by the FDA, the EMA, and Swissmedic: An Assessment of the International Harmonization of Drugs

Authors

Minette-Joëlle Zeukeng, University of Geneva
Enrique Seoane-Vazquez, Chapman UniversityFollow
Pascal Bonnabry, University of Geneva

Document Type

Article

Publication Date

5-26-2018

Comments

This article was originally published in European Journal of Clinical Pharmacology , volume 74, in 2018. https://doi.org/10.1007/s00228-018-2486-5

The Link to Full Text button above directs users to a free read-only version of the article.

Recommended Citation

Zeukeng MJ, Seoane-Vazquez E, Bonnabry P. Response to the letter to the Editor regarding Zeukeng et al.'s article A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs. Eur J Clin Pharmacol. 2018;74(9):1199-1200. https://doi.org/10.1007/s00228-018-2486-5

Copyright

Springer